June 23 (Reuters) - Sana Biotechnology Inc SANA.O:
SANA BIOTECHNOLOGY ANNOUNCES POSITIVE SIX-MONTH CLINICAL RESULTS FROM TYPE 1 DIABETES STUDY OF ISLET CELL TRANSPLANTATION WITHOUT IMMUNOSUPPRESSION
SANA BIOTECHNOLOGY INC - STUDY SHOWS POTENTIAL TO TREAT TYPE 1 DIABETES WITHOUT IMMUNOSUPPRESSION
SANA BIOTECHNOLOGY INC - SIX-MONTH RESULTS SHOW SANA'S ISLET CELLS SAFE AND FUNCTIONAL
Source text: ID:nGNXbncjDK
Further company coverage: SANA.O
((Reuters.Briefs@thomsonreuters.com;))